Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Costa · SciRah

Researcher profile · Semantic Scholar

F. Costa

Share profile

F. Costa — researcher profile on SciRah

h-index: 26
Works: 88
Citations: 7,277

Most-cited papers

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
M. Valgimigli, H. Bueno, R. Byrne, J. Collet +51 more
2018European Journal of Cardio-Thoracic Surgery2,074 citations Open access
Semantic Scholar
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]
M. Valgimigli, H. Bueno, R. Byrne, J. Collet +13 more
2017Kardiologia polska1,388 citations Open access
Semantic Scholar
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
F. Costa, D. Klaveren, S. James, D. Heg +15 more
2017The Lancet983 citations Open access
Semantic Scholar
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
J. Udell, Marc P. Bonaca, J. Collet, A. Lincoff +10 more
2015European Heart Journal373 citations Open access
Semantic Scholar
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial
M. Valgimigli, F. Costa, Y. Lokhnygina, R. Clare +10 more
2016European Heart Journal312 citations Open access
Semantic Scholar
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
E. Navarese, F. Andreotti, V. Schulze, M. Kołodziejczak +8 more
2015British medical journal303 citations Open access
Semantic Scholar
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
F. Costa, D. van Klaveren, F. Feres, S. James +11 more
2019Journal of the American College of Cardiology285 citations Open access
Semantic Scholar
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.
S. Ariotti, M. Adamo, F. Costa, A. Patialiakas +17 more
2016JACC: Cardiovascular Interventions156 citations Open access
Semantic Scholar
Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
M. Valgimigli, H. Bueno, R. Byrne, J. Collet +13 more
2018Revista Española de Cardiología116 citations
Semantic Scholar
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
F. Costa, C. Montalto, M. Branca, Sung-Jin Hong +19 more
2022European Heart Journal112 citations Open access
Semantic Scholar
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) t
F. Costa, P. Vranckx, S. Leonardi, E. Moscarella +5 more
2015European Heart Journal83 citations Open access
Semantic Scholar
Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
F. Costa, J. Tijssen, S. Ariotti, S. Giatti +7 more
2015Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease75 citations Open access
Semantic Scholar
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).
M. Valgimigli, H. G. Garcia Garcia, B. Vrijens, P. Vranckx +22 more
2018European Heart Journal73 citations Open access
Semantic Scholar
The Rotterdam Radial Access Research: Ultrasound-Based Radial Artery Evaluation for Diagnostic and Therapeutic Coronary Procedures
F. Costa, M. V. van Leeuwen, J. Daemen, R. Diletti +7 more
2016Circulation. Cardiovascular Interventions71 citations Open access
Semantic Scholar
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
G. Gargiulo, F. Costa, S. Ariotti, S. Biscaglia +6 more
2016American Heart Journal68 citations Open access
Semantic Scholar
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey.
M. Valgimigli, F. Costa, R. Byrne, M. Haude +2 more
2015EuroIntervention50 citations Open access
Semantic Scholar
Impact of vascular access on acute kidney injury after percutaneous coronary intervention.
Giuseppe Andò, F. Costa, O. Trio, G. Oreto +1 more
2016Cardiovascular Revascularization Medicine45 citations
Semantic Scholar
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration.
F. Costa, M. Adamo, S. Ariotti, G. Ferrante +5 more
2016EuroIntervention43 citations
Semantic Scholar
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
M. Valgimigli, S. Ariotti, F. Costa
2015European Heart Journal38 citations
Semantic Scholar
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.
Giuseppe Andò, F. Costa
2019International Journal of Cardiology37 citations
Semantic Scholar
Incidence, prognostic impact, and optimal definition of contrast‐induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all‐comer PRODIGY trial
G. Crimi, S. Leonardi, F. Costa, S. Ariotti +3 more
2015Catheterization and cardiovascular interventions37 citations
Semantic Scholar
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches
R. Scalise, A. Salito, A. Polimeni, V. Garcia-Ruiz +5 more
2019Journal of Clinical Medicine36 citations Open access
Semantic Scholar
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.
F. Costa, M. Valgimigli, P. Steg, Deepak L. Bhatt +7 more
2020European Heart Journal - Cardiovascular Pharmacotherapy32 citations Open access
Semantic Scholar
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
Jean-Philippe Collet, M. Roffi, R. Byrne, F. Costa +42 more
2018European Heart Journal32 citations Open access
Semantic Scholar
Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis.
F. Costa, M. Adamo, S. Ariotti, E. Navarese +2 more
2015International Journal of Cardiology31 citations
Semantic Scholar
Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
G. Crimi, S. Leonardi, F. Costa, M. Adamo +2 more
2016International Journal of Cardiology29 citations
Semantic Scholar
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis.
A. Munafò, C. Montalto, M. Franzino, L. Pistelli +13 more
2023European Heart Journal - Cardiovascular Pharmacotherapy25 citations
Semantic Scholar
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies
F. Costa, S. Windecker, M. Valgimigli
2017Drugs25 citations
Semantic Scholar
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making.
F. Costa, D. van Klaveren, A. Colombo, F. Feres +7 more
2020American Heart Journal24 citations Open access
Semantic Scholar
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: a meta-analysis of 22,108 patients.
Giuseppe Andò, F. Costa, I. Boretti, O. Trio +1 more
2015International Journal of Cardiology24 citations
Semantic Scholar
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials.
C. Montalto, F. Costa, S. Leonardi, A. Micari +6 more
2022European Heart Journal - Cardiovascular Pharmacotherapy23 citations
Semantic Scholar
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization
F. Costa, S. Ariotti, M. Valgimigli, P. Kolh +1 more
2015Journal of Cardiovascular Translational Research22 citations Open access
Semantic Scholar
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis.
G. Giustino, F. Costa
2019JACC: Cardiovascular Interventions21 citations Open access
Semantic Scholar
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short.
F. Costa, M. Valgimigli
2018Cardiovascular Diagnosis and Therapy18 citations Open access
Semantic Scholar
Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
Alessandro Caracciolo, P. Mazzone, G. Laterra, V. Garcia-Ruiz +8 more
2019Journal of Clinical Medicine17 citations Open access
Semantic Scholar
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach?
Giuseppe Andò, F. Costa
2015Postepy w kardiologii interwencyjnej = Advances in interventional cardiology13 citations Open access
Semantic Scholar
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus: Insights From a Patient-Level Pooled Analysis of SYNTAX, RESOLUTE, and LEADERS Trials
C. Campos, F. Costa, H. Garcia-Garcia, C. Bourantas +5 more
2015Circulation. Cardiovascular Interventions13 citations Open access
Semantic Scholar
Coronary stent selection and optimal course of dual antiplatelet therapy in patients at high bleeding or thrombotic risk: navigating between limited evidence and clinical concerns
S. Ariotti, F. Costa, M. Valgimigli
2015Current Opinion in Cardiology12 citations
Semantic Scholar
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis.
C. Montalto, A. Munafò, L. Arzuffi, M. Casula +5 more
2022Hellenic Journal of Cardiology11 citations Open access
Semantic Scholar
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization
Guillaume Marquis-Gravel, M. Neely, M. Valgimigli, F. Costa +8 more
2020Circulation. Cardiovascular Quality and Outcomes11 citations Open access
Semantic Scholar
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?
F. Costa, S. Brugaletta, A. Pernigotti, Eduardo Flores-Ulmanzor +16 more
2019Circulation. Cardiovascular Interventions11 citations Open access
Semantic Scholar
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta‐analysis
A. Saglietto, F. D'Ascenzo, D. Errigo, S. Leonardi +15 more
2020Catheterization and cardiovascular interventions9 citations
Semantic Scholar
Transfusion and Mortality After Transcatheter Aortic Valve Replacement: Association or Causation?
F. Costa, Mauricio G. Cohen
2020Circulation. Cardiovascular Interventions9 citations Open access
Semantic Scholar
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease.
G. Marquis-Gravel, S. Mehta, M. Valgimigli, G. Levine +8 more
2019Canadian Journal of Cardiology9 citations
Semantic Scholar
TRADEOFF BETWEEN MYOCARDIAL INFARCTION VERSUS BLEEDING TYPES ON MORTALITY AFTER ACUTE CORONARY SYNDROME: LESSONS FROM THE THROMBIN RECEPTOR ANTAGONIST FOR CLINICAL EVENT REDUCTION IN ACUTE CORONARY SYNDROME (TRACER) RANDOMIZED TRIAL
F. Costa, M. Valgimigli, Y. Lokhnygina, R. Clare +10 more
20169 citations Open access
Semantic Scholar
Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities.
F. Costa, M. Valgimigli
2015Journal of the American College of Cardiology9 citations Open access
Semantic Scholar
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.
M. Adamo, S. Ariotti, F. Costa, S. Curello +5 more
2016JACC: Cardiovascular Interventions8 citations Open access
Semantic Scholar
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
Maria C. Castelijns, S. Hageman, M. Teraa, M. G. van der Meer +4 more
2023American Heart Journal7 citations Open access
Semantic Scholar
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators.
P. Sabouret, D. Angoulvant, A. Pathak, M. Fysekidis +4 more
2021Panminerva Medica (Testo stampato)7 citations
Semantic Scholar
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients
P. Sabouret, M. Savage, D. Fischman, F. Costa
2020American Journal of Cardiovascular Drugs7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Valgimigli×39
Invite
M. Valgimigli — researcher profile on SciRah
S. Windecker×14
Invite
S. Windecker — researcher profile on SciRah
S. Ariotti×11
Invite
S. Ariotti — researcher profile on SciRah
P. Vranckx×9
Invite
P. Vranckx — researcher profile on SciRah

×9

Invite

S. Leonardi — researcher profile on SciRah

Invite

P. Steg — researcher profile on SciRah

Deepak L. Bhatt×7

Invite

Deepak L. Bhatt — researcher profile on SciRah

Giuseppe Andò×7

Invite

Giuseppe Andò — researcher profile on SciRah

G. Montalescot×6

Invite

G. Montalescot — researcher profile on SciRah

Invite

M. Roffi — researcher profile on SciRah

Invite

R. Byrne — researcher profile on SciRah

Invite

P. Jüni — researcher profile on SciRah